» Articles » PMID: 36406408

Leukocyte Metabolism in Obese Type 2 Diabetic Individuals Associated with COVID-19 Severity

Abstract

Recent studies show that the metabolic characteristics of different leukocytes, such as, lymphocytes, neutrophils, and macrophages, undergo changes both in the face of infection with SARS-CoV-2 and in obesity and type 2 diabetes mellitus (DM2) condition. Thus, the objective of this review is to establish a correlation between the metabolic changes caused in leukocytes in DM2 and obesity that may favor a worse prognosis during SARS-Cov-2 infection. Chronic inflammation and hyperglycemia, specific and usual characteristics of obesity and DM2, contributes for the SARS-CoV-2 replication and metabolic disturbances in different leukocytes, favoring the proinflammatory response of these cells. Thus, obesity and DM2 are important risk factors for pro-inflammatory response and metabolic dysregulation that can favor the occurrence of the cytokine storm, implicated in the severity and high mortality risk of the COVID-19 in these patients.

Citing Articles

Role of Gut Microbiota in Long COVID: Impact on Immune Function and Organ System Health.

Pathak A, Agrawal D Arch Microbiol Immunol. 2025; 9(1):38-53.

PMID: 40051430 PMC: 11883900.


Integration of individualized and population-level molecular epidemiology data to model COVID-19 outcomes.

Ling-Hu T, Simons L, Dean T, Rios-Guzman E, Caputo M, Alisoltani A Cell Rep Med. 2024; 5(1):101361.

PMID: 38232695 PMC: 10829796. DOI: 10.1016/j.xcrm.2023.101361.

References
1.
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View

2.
Haczeyni F, Bell-Anderson K, Farrell G . Causes and mechanisms of adipocyte enlargement and adipose expansion. Obes Rev. 2017; 19(3):406-420. DOI: 10.1111/obr.12646. View

3.
Marcos-Jimenez A, Sanchez-Alonso S, Alcaraz-Serna A, Esparcia L, Lopez-Sanz C, Sampedro-Nunez M . Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients. Eur J Immunol. 2020; 51(3):634-647. PMC: 7753288. DOI: 10.1002/eji.202048858. View

4.
Channappanavar R, Fehr A, Zheng J, Wohlford-Lenane C, Abrahante J, Mack M . IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest. 2019; 129(9):3625-3639. PMC: 6715373. DOI: 10.1172/JCI126363. View

5.
Booth C, Matukas L, Tomlinson G, Rachlis A, Rose D, Dwosh H . Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003; 289(21):2801-9. DOI: 10.1001/jama.289.21.JOC30885. View